Cargando…

Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants

Mostrar otras versiones (2)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected at least 180 million people since its identification as the cause of the current COVID-19 pandemic. The rapid pace of vaccine development has resulted in multiple vaccines already in use worldwide. The contemporaneous emergenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikegame, Satoshi, Siddiquey, Mohammed N. A., Hung, Chuan-Tien, Haas, Griffin, Brambilla, Luca, Oguntuyo, Kasopefoluwa Y., Kowdle, Shreyas, Chiu, Hsin-Ping, Stevens, Christian S., Vilardo, Ariel Esteban, Edelstein, Alexis, Perandones, Claudia, Kamil, Jeremy P., Lee, Benhur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313705/ https://www.ncbi.nlm.nih.gov/pubmed/34312390 http://dx.doi.org/10.1038/s41467-021-24909-9

Ejemplares similares

Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
por: Ikegame, Satoshi, et al.
Publicado: (2021)

Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
por: Ikegame, Satoshi, et al.
Publicado: (2021)

Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesis
por: Stevens, Christian S, et al.
Publicado: (2023)

Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera
por: Oguntuyo, Kasopefoluwa Y., et al.
Publicado: (2020)

Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera
por: Oguntuyo, Kasopefoluwa Y., et al.
Publicado: (2021)

Proteases and variants: context matters for SARS-CoV-2 entry assays
por: Stevens, Christian S, et al.
Publicado: (2021)

Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina
por: Chahla, Rossana Elena, et al.
Publicado: (2021)

The arrival of Sputnik V
por: Balakrishnan, Vijay Shankar
Publicado: (2020)

The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time
por: Fox, Alisa, et al.
Publicado: (2022)

Zoonotic potential of a novel bat morbillivirus
por: Lee, Benhur, et al.
Publicado: (2021)

Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2
por: Klingler, Jéromine, et al.
Publicado: (2020)

Sputnik V vaccine goes global
por: Lawton, Graham
Publicado: (2021)

Controversy surrounding the Sputnik V vaccine
por: Cazzola, Mario, et al.
Publicado: (2021)

Antibody durability at 1 year after Sputnik V vaccination
por: Sanchez, Lautaro, et al.
Publicado: (2022)

Long Term Immune Response Produced by the SputnikV Vaccine
por: Martynova, Ekaterina, et al.
Publicado: (2021)

Can children of the Sputnik V vaccine recipients become symptomatic?
por: Mehraeen, Esmaeil, et al.
Publicado: (2021)

Sputnik‐V vaccine‐induced panniculitis as a local reactions
por: Sahraei, Zahra, et al.
Publicado: (2022)

Phenotypic Changes in T and NK Cells Induced by Sputnik V Vaccination
por: Boyko, Anna A., et al.
Publicado: (2023)

Crystal structure and solution state of the C-terminal head region of the narmovirus receptor binding protein
por: Stelfox, Alice J., et al.
Publicado: (2023)

Development of Peptic Ulcer following Second Shot of Sputnik V Vaccine: A Case Report and Literature Review of Rare Side Effects of Sputnik V Vaccine
por: Hasanzarrini, Maryam, et al.
Publicado: (2023)

Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose
por: Rossi, Andres H., et al.
Publicado: (2021)

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals
por: Lapa, Daniele, et al.
Publicado: (2022)

Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance
por: Sukhikh, Gennady T., et al.
Publicado: (2022)

Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients
por: Laham, Gustavo, et al.
Publicado: (2022)

Sputnik V COVID-19 vaccine candidate appears safe and effective
por: Jones, Ian, et al.
Publicado: (2021)

Sputnik V, vaccin russe en orbite à l’EMA
por: Dalmat, Yann-Mickael
Publicado: (2021)

Vaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine
por: Herrera-Comoglio, Raquel, et al.
Publicado: (2022)

Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing
por: Park, Arnold, et al.
Publicado: (2016)

Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2
por: Klingler, Jéromine, et al.
Publicado: (2020)

SARS-CoV-2-specific T Cell Immunity after Vaccination with Sputnik V and BBIBP-CorV
por: Babrukevich, Darya, et al.
Publicado: (2022)

Sputnik, mi amor /
por: Murakami, Haruki, 1949-
Publicado: (2009)

Sputnik, mi amor/
por: Murakami, Haruki 1949-
Publicado: (2012)

Sputnik, mi amor /
por: Murakami, Haruki, 1949-

Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
por: Jeewandara, Chandima, et al.
Publicado: (2022)

Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance
por: Shkoda, Andrey S., et al.
Publicado: (2022)

Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study
por: Yegorov, Sergey, et al.
Publicado: (2022)

Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive Model
por: Liu, Kuan-Ting, et al.
Publicado: (2022)

Antibody responses induced by Sputnik V vaccine in individuals previously infected with SARS-CoV-2
por: Raiden, Silvina, et al.
Publicado: (2021)

Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina
por: Ojeda, Diego S., et al.
Publicado: (2021)

Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis
por: Pereson, Matías J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pe3pmvs3ofjgssi9i89bfp407e